Want to see HK:3347 full AI Analyst Report?
Hangzhou Tigermed Consulting Co., Ltd. Class H (3347) Ratios
Hangzhou Tigermed Consulting Co., Ltd. Class H Ratios
HK:3347's free cash flow for Q3 2026 was $320.49M. For the 2026 fiscal year, HK:3347's free cash flow was decreased by $-25.04M and operating cash flow was $345.53M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.18 | 1.72 | 2.74 | 2.98 | 4.50 |
| Quick Ratio | 2.16 | 1.71 | 2.74 | 2.97 | 4.50 |
| Cash Ratio | 0.63 | 0.56 | 1.79 | 2.11 | 3.54 |
| Solvency Ratio | 0.30 | 0.16 | 0.45 | 0.48 | 0.98 |
| Operating Cash Flow Ratio | 0.39 | 0.30 | 0.28 | 0.36 | 0.59 |
| Short-Term Operating Cash Flow Coverage | 2.19 | 0.57 | 0.58 | 0.73 | 2.89 |
| Net Current Asset Value | $ 2.07B | $ 1.69B | $ 6.12B | $ 6.34B | $ 7.72B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.09 | 0.10 | 0.10 | 0.05 |
| Debt-to-Equity Ratio | 0.07 | 0.13 | 0.13 | 0.14 | 0.07 |
| Debt-to-Capital Ratio | 0.07 | 0.11 | 0.12 | 0.13 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.02 | 0.02 | 0.01 | 0.00 |
| Financial Leverage Ratio | 1.35 | 1.39 | 1.41 | 1.40 | 1.31 |
| Debt Service Coverage Ratio | 2.03 | 0.44 | 1.23 | 1.36 | 6.97 |
| Interest Coverage Ratio | 11.15 | 4.70 | 20.74 | 31.05 | 77.04 |
| Debt to Market Cap | 0.03 | 0.09 | 0.09 | 0.03 | 0.01 |
| Interest Debt Per Share | 1.82 | 3.21 | 3.41 | 3.34 | 1.40 |
| Net Debt to EBITDA | -0.21 | 0.51 | -1.58 | -1.72 | -1.89 |
| Profitability Margins | |||||
| Gross Profit Margin | 27.41% | 33.95% | 38.58% | 39.64% | 43.55% |
| EBIT Margin | 16.01% | 12.20% | 35.33% | 37.66% | 71.15% |
| EBITDA Margin | 20.79% | 17.11% | 39.47% | 41.40% | 74.77% |
| Operating Profit Margin | 14.77% | 10.06% | 33.68% | 36.45% | 36.81% |
| Pretax Profit Margin | 14.68% | 10.06% | 33.70% | 36.49% | 70.67% |
| Net Profit Margin | 12.99% | 6.14% | 27.42% | 28.32% | 55.13% |
| Continuous Operations Profit Margin | 11.78% | 6.78% | 29.12% | 32.06% | 65.06% |
| Net Income Per EBT | 88.50% | 60.97% | 81.37% | 77.61% | 78.01% |
| EBT Per EBIT | 99.39% | 100.01% | 100.06% | 100.12% | 192.00% |
| Return on Assets (ROA) | 3.13% | 1.41% | 6.82% | 7.31% | 12.11% |
| Return on Equity (ROE) | 4.24% | 1.96% | 9.63% | 10.25% | 15.86% |
| Return on Capital Employed (ROCE) | 3.95% | 2.66% | 9.74% | 10.89% | 9.00% |
| Return on Invested Capital (ROIC) | 3.11% | 1.66% | 7.81% | 8.88% | 8.10% |
| Return on Tangible Assets | 3.61% | 1.61% | 7.63% | 8.15% | 13.24% |
| Earnings Yield | 2.70% | 1.62% | 7.31% | 2.91% | 4.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.66 | 1.67 | 2.04 | 2.34 | 2.48 |
| Payables Turnover | 13.36 | 16.95 | 18.19 | 27.08 | 19.90 |
| Inventory Turnover | 119.50 | 136.47 | 193.84 | 192.62 | 482.83 |
| Fixed Asset Turnover | 4.00 | 3.92 | 5.01 | 5.34 | 4.64 |
| Asset Turnover | 0.24 | 0.23 | 0.25 | 0.26 | 0.22 |
| Working Capital Turnover Ratio | 2.29 | 1.34 | 1.01 | 0.90 | 0.55 |
| Cash Conversion Cycle | 195.35 | 200.01 | 161.02 | 144.56 | 129.54 |
| Days of Sales Outstanding | 219.61 | 218.87 | 179.20 | 156.15 | 147.13 |
| Days of Inventory Outstanding | 3.05 | 2.67 | 1.88 | 1.89 | 0.76 |
| Days of Payables Outstanding | 27.31 | 21.53 | 20.06 | 13.48 | 18.34 |
| Operating Cycle | 222.66 | 221.54 | 181.09 | 158.04 | 147.88 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.30 | 1.27 | 1.33 | 1.57 | 1.64 |
| Free Cash Flow Per Share | 1.05 | 0.86 | 0.97 | 1.05 | 1.22 |
| Dividend Paid and CapEx Coverage Ratio | 2.00 | 1.10 | 1.27 | 1.44 | 2.18 |
| Capital Expenditure Coverage Ratio | 5.22 | 3.08 | 3.67 | 3.03 | 3.86 |
| Operating Cash Flow Coverage Ratio | 0.76 | 0.42 | 0.41 | 0.48 | 1.20 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.17 | 0.16 | 0.19 | 0.27 |
| Free Cash Flow Yield | 2.75% | 2.96% | 3.02% | 1.32% | 1.51% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 37.10 | 61.55 | 13.69 | 34.32 | 24.36 |
| Price-to-Sales (P/S) Ratio | 4.81 | 3.79 | 3.75 | 9.72 | 13.43 |
| Price-to-Book (P/B) Ratio | 1.57 | 1.21 | 1.32 | 3.52 | 3.86 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 36.40 | 33.79 | 33.13 | 75.77 | 66.35 |
| Price-to-Operating Cash Flow Ratio | 29.42 | 22.81 | 24.09 | 50.73 | 49.17 |
| Price-to-Earnings Growth (PEG) Ratio | 0.31 | -0.77 | 15.88 | -1.15 | 0.48 |
| Enterprise Value Multiple | 22.95 | 22.66 | 7.94 | 21.75 | 16.07 |
| Enterprise Value | 32.60B | 25.60B | 23.12B | 63.81B | 62.65B |
| EV to EBITDA | 22.95 | 22.66 | 7.94 | 21.75 | 16.07 |
| EV to Sales | 4.77 | 3.88 | 3.13 | 9.01 | 12.02 |
| EV to Free Cash Flow | 36.07 | 34.57 | 27.64 | 70.21 | 59.38 |
| EV to Operating Cash Flow | 29.15 | 23.34 | 20.10 | 47.01 | 44.01 |
| Tangible Book Value Per Share | 23.76 | 23.70 | 24.64 | 22.97 | 21.39 |
| Shareholders’ Equity Per Share | 24.34 | 23.90 | 24.30 | 22.65 | 20.87 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.33 | 0.14 | 0.12 | 0.08 |
| Revenue Per Share | 7.94 | 7.63 | 8.53 | 8.19 | 6.00 |
| Net Income Per Share | 1.03 | 0.47 | 2.34 | 2.32 | 3.31 |
| Tax Burden | 0.89 | 0.61 | 0.81 | 0.78 | 0.78 |
| Interest Burden | 0.92 | 0.82 | 0.95 | 0.97 | 0.99 |
| Research & Development to Revenue | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 |
| SG&A to Revenue | 0.05 | 0.05 | 0.04 | 0.04 | 0.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Income Quality | 1.39 | 2.45 | 0.57 | 0.60 | 0.42 |
Currency in CNY
